Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:PRNB

Principia Biopharma (PRNB) Stock Price, News & Analysis

Principia Biopharma logo

About Principia Biopharma Stock (NASDAQ:PRNB)

Advanced Chart

Key Stats

Today's Range
$100.05
$100.05
50-Day Range
$99.95
$100.27
52-Week Range
$25.35
$101.89
Volume
N/A
Average Volume
729,676 shs
Market Capitalization
$3.32 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PRNB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Principia Biopharma and its competitors with MarketBeat's FREE daily newsletter.

PRNB Stock News Headlines

Digital Dollar Alert: Protect Your Wealth Before It’s Too Late
134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts warn a programmable dollar could erase your privacy and control your spending. A free guide reveals how to protect your savings before the system goes live.
Principia College names new president
See More Headlines

PRNB Stock Analysis - Frequently Asked Questions

Principia Biopharma Inc. (NASDAQ:PRNB) posted its quarterly earnings results on Thursday, August, 6th. The company reported $0.31 earnings per share (EPS) for the quarter, topping the consensus estimate of ($1.03) by $1.34. The company earned $50 million during the quarter, compared to analysts' expectations of $50 million.

Principia Biopharma (PRNB) raised $75 million in an initial public offering (IPO) on Friday, September 14th 2018. The company issued 4,700,000 shares at a price of $15.00-$17.00 per share. BofA Merrill Lynch, Leerink Partners and Wells Fargo Securities served as the underwriters for the IPO and Baird was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that Principia Biopharma investors own include Pfizer (PFE), Advanced Micro Devices (AMD), AbbVie (ABBV), Bristol Myers Squibb (BMY), Cisco Systems (CSCO), QUALCOMM (QCOM) and VBI Vaccines (VBIV).

Company Calendar

Last Earnings
8/06/2020
Today
8/03/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:PRNB
CIK
N/A
Fax
N/A
Employees
65
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($2.09)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$53.79 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-23.08%
Return on Assets
-21.11%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
17.01
Quick Ratio
17.01

Sales & Book Value

Annual Sales
$35.16 million
Price / Sales
94.50
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$10.95 per share
Price / Book
9.14

Miscellaneous

Outstanding Shares
33,209,000
Free Float
N/A
Market Cap
$3.32 billion
Optionable
Not Optionable
Beta
0.86
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NASDAQ:PRNB) was last updated on 8/3/2025 by MarketBeat.com Staff
From Our Partners